Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
81.99
-2.88 (-3.39%)
Jul 13, 2026, 1:43 PM EDT - Market open
Cytokinetics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $119 → $117 | Buy | Maintains | $119 → $117 | +42.70% | Jul 7, 2026 |
| UBS | UBS | Buy Upgrades $115 | Buy | Upgrades | $115 | +40.26% | Jun 29, 2026 |
| Needham | Needham | Buy Maintains $102 | Buy | Maintains | $102 | +24.41% | Jun 29, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $100 → $118 | Buy | Maintains | $100 → $118 | +43.92% | Jun 23, 2026 |
| Citi | Citi | Buy Reiterates $99 | Buy | Reiterates | $99 | +20.75% | Jun 17, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $103 | Buy | Maintains | $103 | +25.63% | Jun 17, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $67 → $83 | Hold | Maintains | $67 → $83 | +1.23% | Jun 17, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $97 | Buy | Maintains | $97 | +18.31% | Jun 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.